Antide (CAS 112568-12-4) – High Purity 99.53% – GMP Manufacturer

描述

Antide (CAS 112568-12-4), also known as Iturelix, is a potent synthetic luteinizing hormone–releasing hormone (LHRH/GnRH) antagonist. By competitively inhibiting GnRH receptors in the pituitary gland, it suppresses the secretion of LH and FSH, thereby exerting strong anti-ovulatory effects while releasing negligible histamine—a notable advantage over earlier generations of GnRH antagonists.

This agent is widely used in reproductive biology and hormone-dependent cancer studies, including prostate cancer research. Manufactured under GMP conditions with purity of 99.53%, Antide ensures high-quality consistency for experimental protocols.

Product Specifications

Mechanism of Action & Research Applications

Antide functions as a GnRH antagonist by binding to GnRH receptors in the pituitary, inhibiting LH and FSH secretion without causing the flare effect seen with agonists. Its high anti-ovulatory activity and minimal histamine release make it a powerful tool for studies of reproductive endocrinology, infertility models, and hormone-sensitive cancers such as prostate cancer.

Side Effects (For Reference Only)

Since Antide is for experimental use only, clinical safety data are limited. Preclinical studies suggest minimal histamine release compared to earlier GnRH antagonists. Researchers should follow laboratory safety protocols strictly.

Disclaimer

This product is intended strictly for laboratory research use only. It is not approved for human or veterinary therapeutic use. Please adhere to institutional safety guidelines when handling.